R. G. Niederhoffer Capital Management Inc adds Monsanto Company (MON) to its portfolio

Monsanto Company (MON) : R. G. Niederhoffer Capital Management Inc added new position in Monsanto Company during the most recent quarter end. The investment management firm now holds 12,200 shares of Monsanto Company which is valued at $1,273,192 , the company said in a statement filed on Aug 2, 2016 with the SEC.Monsanto Company makes up approximately 7.78% of R. G. Niederhoffer Capital Management Inc’s portfolio.

Other Hedge Funds, Including , Spot Trading L.l.c boosted its stake in MON in the latest quarter, The investment management firm added 57,112 additional shares and now holds a total of 58,551 shares of Monsanto Company which is valued at $6,110,382. Monsanto Company makes up approx 0.81% of Spot Trading L.l.c’s portfolio.Signaturefd boosted its stake in MON in the latest quarter, The investment management firm added 415 additional shares and now holds a total of 1,083 shares of Monsanto Company which is valued at $115,632. Monsanto Company makes up approx 0.02% of Signaturefd’s portfolio.Gateway Investment Advisers reduced its stake in MON by selling 67,944 shares or 14.67% in the most recent quarter. The Hedge Fund company now holds 395,286 shares of MON which is valued at $39,975,273. Monsanto Company makes up approx 0.34% of Gateway Investment Advisers’s portfolio.

Monsanto Company closed down -0.18 points or -0.17% at $106.75 with 13,66,678 shares getting traded on Monday. Post opening the session at $107.5, the shares hit an intraday low of $106.41 and an intraday high of $107.655 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Monsanto Company reported $2.17 EPS for the quarter, missing the analyst consensus estimate by $ -0.23 based on the information available during the earnings call on Jun 29, 2016. Analyst had a consensus of $2.40. The company had revenue of $4189.00 million for the quarter, compared to analysts expectations of $4487.57 million. The company’s revenue was down -8.5 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $2.39 EPS.

Many Wall Street Analysts have commented on Monsanto Company. Monness Crespi & Hardt Upgraded Monsanto Company on Aug 8, 2016 to ” Buy”, Price Target of the shares are set at $130.Monsanto Company was Upgraded by Jefferies to ” Buy” on May 25, 2016.

Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds biotechnology trait products and herbicides provide farmers with solutions that improve productivity reduce the costs of farming and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics and Agricultural Productivity. Through its Seeds and Genomics segment it produces seed brands including DEKALB Asgrow Deltapine Seminis and De Ruiter and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Leave a Reply

Monsanto Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Monsanto Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.